Wed-20-10-2021, 10:31 AM
Update: The Committee for Medicinal Products for Human Use (CHMP) have recommended the approval of Skyrizi for psoriatic arthritis.
Usually that means it will soon be available for use in the EU.
Usually that means it will soon be available for use in the EU.